<b>Conclusions</b>: The results support the role of ANGPTL4 as a potential biomarker in metabolic disturbances and complications in T2DM, while ANGPTL8 remains mainly insignificant after correction for potential confounding factors. The gene discussed is ANGPTL8; the disease is type 2 diabetes mellitus.